These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15464913)

  • 21. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
    Har-Noy M; Zeira M; Weiss L; Fingerut E; Or R; Slavin S
    Leuk Res; 2009 Apr; 33(4):525-38. PubMed ID: 18834631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines: an innovative approach to treating cancer.
    Pazdur MP; Jones JL
    J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Redirected T cell-based antileukemia adoptive immunotherapy using tumor antigen-specific TCR gene transfer].
    Fujiwara H
    Rinsho Ketsueki; 2014 Jun; 55(6):657-69. PubMed ID: 24975335
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on vaccines for solid tumors.
    Gajewski TF
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):158-9. PubMed ID: 16166944
    [No Abstract]   [Full Text] [Related]  

  • 27. Q&A: Evidence presenter. Interview by Marian Turner.
    Palucka K
    Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
    [No Abstract]   [Full Text] [Related]  

  • 28. Glioma-specific antigens for immune tumor therapy.
    Skog J
    Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic cancer vaccines.
    Morris LF; Ribas A
    Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are vaccines making a comeback in non-small-cell lung cancer?
    Nemunaitis JJ
    J Clin Oncol; 2008 Mar; 26(9):1402-3. PubMed ID: 18349390
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges for cancer vaccine development.
    Tabi Z; Man S
    Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase as a universal tumor antigen for cancer vaccines.
    Beatty GL; Vonderheide RH
    Expert Rev Vaccines; 2008 Sep; 7(7):881-7. PubMed ID: 18767939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell vaccines for leukemia patients.
    Schmitt A; Hus I; Schmitt M
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy for pancreatic cancer - science driving clinical progress.
    Laheru D; Jaffee EM
    Nat Rev Cancer; 2005 Jun; 5(6):459-67. PubMed ID: 15905855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer vaccines and T cell therapy.
    Rezvani K; Brody JD; Kohrt HE; Logan AC; Advani R; Czerwinski DK; Weng WK; Negrin RS; Carlton V; Faham M; Levy R; Barrett J
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S97-S101. PubMed ID: 23041602
    [No Abstract]   [Full Text] [Related]  

  • 37. Current immunotherapeutic strategies in pancreatic cancer.
    Plate JM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):919-43, xi. PubMed ID: 18022552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of tumor cell-based vaccines.
    Copier J; Dalgleish A
    Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for vaccine therapy for pancreatic cancer.
    Gaudernack G
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):299-314. PubMed ID: 16549329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.